Bank of New York Mellon Corp - MATINAS BIOPHARMA HLDGS INC ownership

MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 49 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of MATINAS BIOPHARMA HLDGS INC
ValueSharesWeighting
Q3 2023$11,720
-80.3%
90,151
-45.4%
0.00%
Q2 2023$59,445
-23.7%
165,125
-0.3%
0.00%
Q1 2023$77,860
-6.0%
165,6590.0%0.00%
Q4 2022$82,830
-21.9%
165,659
-0.4%
0.00%
Q3 2022$106,000
-19.1%
166,2490.0%0.00%
Q2 2022$131,000
-3.7%
166,249
-1.9%
0.00%
Q1 2022$136,000
-20.5%
169,4600.0%0.00%
Q4 2021$171,000
-22.3%
169,4600.0%0.00%
Q3 2021$220,000
+67.9%
169,4600.0%0.00%
Q2 2021$131,000
-32.1%
169,460
-7.6%
0.00%
Q1 2021$193,000
-28.8%
183,427
-8.1%
0.00%
Q4 2020$271,000
+77.1%
199,5260.0%0.00%
Q3 2020$153,000
-0.6%
199,5260.0%0.00%
Q2 2020$154,000
+28.3%
199,5260.0%0.00%
Q1 2020$120,000
-65.8%
199,526
+29.1%
0.00%
Q4 2019$351,000
+261.9%
154,5580.0%0.00%
Q3 2019$97,000
-26.5%
154,5580.0%0.00%
Q2 2019$132,000
+116.4%
154,558
+175.7%
0.00%
Q1 2019$61,000
+79.4%
56,057
-2.9%
0.00%
Q4 2018$34,000
-35.8%
57,7380.0%0.00%
Q3 2018$53,000
+112.0%
57,7380.0%0.00%
Q2 2018$25,000
-81.5%
57,738
-67.4%
0.00%
Q1 2018$135,000
-33.5%
176,849
+0.9%
0.00%
Q4 2017$203,000
-7.3%
175,325
+5.5%
0.00%
Q3 2017$219,000
-22.3%
166,242
-0.2%
0.00%
Q2 2017$282,000166,5740.00%
Other shareholders
MATINAS BIOPHARMA HLDGS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 3,960,900$3,129,0000.97%
COURAGE CAPITAL MANAGEMENT LLC 331,846$262,0000.43%
Arkadios Wealth Advisors 1,399,000$1,105,0000.16%
Kingsbury Capital Investment Advisors LLC 119,949$95,0000.13%
NEVILLE RODIE & SHAW INC 1,753,500$1,385,0000.12%
JTC Employer Solutions Trustee Ltd 775,000$630,0000.08%
Platform Technology Partners 142,410$113,0000.06%
National Wealth Management Group, LLC 44,100$34,8390.04%
Main Street Financial Solutions, LLC 400,826$317,0000.04%
STALEY CAPITAL ADVISERS INC 600,000$474,0000.03%
View complete list of MATINAS BIOPHARMA HLDGS INC shareholders